Coronavirus Update:What patients and families need to know
T-Cells from recovered COVID-19 patients show promise to protect vulnerable patients from infection
T-cells taken from the blood of people who recovered from a COVID-19 infection can be successfully multiplied in the lab and maintain the ability to effectively target proteins that are key to the virus’s function, according to a study published Oct. 26, 2020, in the journal Blood. Learn more about this study.
About the Expert
Catherine Bollard, M.D., M.B.Ch.B.
Director, Center for Cancer & Immunology Research
Bosworth Chair for Cancer Biology
Director, Program for Cell Enhancement and Technologies for Immunotherapy (CETI)
Attending Physician, Division of Bone and Marrow Transplantation
Michael Keller, MD
Director, Translational Research Laboratory - CETI
Director, Jeffrey Modell Diagnostic and Research Center for Primary Immunodeficiency Disorders
Make an Appointment
Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.
Make it happen